Patrik Dykiel

A New-Generation Ultra-Long-Acting Basal Insulin With a Bolus Boost Compared With Insulin Glargine in Insulin-Naïve People With Type 2 Diabetes

Tim Heise, Cees J. Tack, Robert Cuddihy et al. · Diabetes Care · 2011 · 96 citations · Full text

Insulin Degludec/Insulin Aspart Administered Once Daily at Any Meal, With Insulin Aspart at Other Meals Versus a Standard Basal-Bolus Regimen in Patients With Type 1 Diabetes

Irl B. Hirsch, Bruce W. Bode, J.P. Courrèges et al. · Diabetes Care · 2012 · 75 citations · Full text

A Novel Insulin Combination of Insulin Degludec and Insulin Aspart Achieves a More Stable Overnight Glucose Profile Than Insulin Glargine: Results from Continuous Glucose Monitoring in a Proof-of-Concept Trial

Andreas Liebl, Jaime A. Davidson, Henriette Mersebach et al. · Journal of Diabetes Science and Technology · 2013 · 27 citations · Full text

Sensitization to secretoglobin and lipocalins in a group of young children with risk of developing respiratory allergy

Mizuho Nagao, Magnus P. Borres, Mayumi Sugimoto et al. · Clinical and Molecular Allergy · 2017 · 11 citations · Full text